{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T04:34:13Z","timestamp":1725510853440},"reference-count":38,"publisher":"Saudi Heart Association","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Saudi Heart Association"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jsha.2012.08.001","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T20:31:24Z","timestamp":1345753884000},"page":"243-252","source":"Crossref","is-referenced-by-count":8,"title":["Prospective observational studies of the management and outcomes in patients with atrial fibrillation: A systematic review"],"prefix":"10.37616","volume":"24","author":[{"given":"Ahmad S.","family":"Hersi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alawi A.","family":"Alsheikh-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Zubaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jassim","family":"Al Suwaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24531","reference":[{"issue":"5","key":"10.1016\/j.jsha.2012.08.001_b0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew\/Paisley study","volume":"86","author":"Stewart","year":"2001","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.jsha.2012.08.001_b0010","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA: the Journal of the American Medical Association"},{"issue":"9","key":"10.1016\/j.jsha.2012.08.001_b0015","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jsha.2012.08.001_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/hrt.2006.099903","article-title":"Rate control in the medical management of atrial fibrillation","volume":"93","author":"Camm","year":"2007","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.jsha.2012.08.001_b0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1524-4733.2006.00124.x","article-title":"Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States","volume":"9","author":"Coyne","year":"2006","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jsha.2012.08.001_b0030","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"issue":"9A","key":"10.1016\/j.jsha.2012.08.001_b0035","doi-asserted-by":"crossref","first-page":"131R","DOI":"10.1016\/S0002-9149(99)00713-4","article-title":"Epidemiology and significance of atrial fibrillation","volume":"84","author":"Ryder","year":"1999","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.jsha.2012.08.001_b0040","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsha.2012.08.001_b0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.165.3.258","article-title":"Rate vs. rhythm control in patients with atrial fibrillation: a meta-analysis","volume":"165","author":"De Denus","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsha.2012.08.001_b0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/europace\/eul106","article-title":"Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies","volume":"8","author":"Van Gelder","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.jsha.2012.08.001_b0055","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM199711063371906","article-title":"Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities","volume":"337","author":"Braunwald","year":"1997","journal-title":"The New England Journal of Medicine (NEJM)"},{"key":"10.1016\/j.jsha.2012.08.001_b0060","series-title":"Initial National Priorities for Comparative effectiveness Research. IOM (Institute of Medicine)","author":"Committee on Comparative Effectiveness Research Prioritization Institute of Medicine","year":"2009"},{"issue":"5","key":"10.1016\/j.jsha.2012.08.001_b0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"The PRISMA group: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"International Journal of Surgery"},{"issue":"7\u20131","key":"10.1016\/j.jsha.2012.08.001_b0070","doi-asserted-by":"crossref","first-page":"82N","DOI":"10.1016\/S0002-9149(98)00589-X","article-title":"The Canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation","volume":"82","author":"Kerr","year":"1998","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.jsha.2012.08.001_b0075","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/ehm308","article-title":"Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)","volume":"28","author":"Friberg","year":"2007","journal-title":"European Heart Journal"},{"issue":"11","key":"10.1016\/j.jsha.2012.08.001_b0080","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.hrthm.2008.08.011","article-title":"Atrial fibrillation progression and management: a 5-year prospective follow-up study","volume":"5","author":"Pappone","year":"2008","journal-title":"Heart Rhythm"},{"issue":"22","key":"10.1016\/j.jsha.2012.08.001_b0085","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1016\/j.jsha.2012.08.001_b0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/europace\/euq006","article-title":"Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon","volume":"12","author":"Ntep-Gweth","year":"2010","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.jsha.2012.08.001_b0095","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.03.034","article-title":"Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)","volume":"58","author":"Camm","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1016\/j.jsha.2012.08.001_b0100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1378\/chest.10-2963","article-title":"Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study","volume":"140","author":"Potpara","year":"2011","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.jsha.2012.08.001_b0105","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.amjcard.2009.11.046","article-title":"Practice patterns among United States cardiologists for managing adults with atrial fibrillation (AFFECTS)","volume":"105","author":"Kowey","year":"2010","journal-title":"The American Journal of Cardiology"},{"issue":"3","key":"10.1016\/j.jsha.2012.08.001_b0110","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pmed.0050067","article-title":"Observational research, randomised trials, and two views of medical science","volume":"5","author":"Vandenbroucke","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jsha.2012.08.001_b0115","unstructured":"Registries for Evaluating Patient Outcomes: A User\u2019s Guide. Agency for Healthcare Research and Quality (AHRQ). 2010; second ed., Publication No. 10-EHC049."},{"issue":"22","key":"10.1016\/j.jsha.2012.08.001_b0120","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA: the Journal of the American Medical Association"},{"issue":"10","key":"10.1016\/j.jsha.2012.08.001_b0125","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"issue":"9697","key":"10.1016\/j.jsha.2012.08.001_b0130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(09)60994-6","article-title":"Mitral stenosis","volume":"374","author":"Chandrashekhar","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jsha.2012.08.001_b0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"10.1016\/j.jsha.2012.08.001_b0140","first-page":"477","article-title":"Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) investigators","volume":"4","author":"Zubaid","year":"2011","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"key":"10.1016\/j.jsha.2012.08.001_b0145","unstructured":"Global Registry of Acute Coronary Events (GRACE) 2012. Scientific Advisory Committee. [Cited 2012 Mar 6]. Available from: <http:\/\/www.outcomes-umassmed.org\/grace\/>."},{"key":"10.1016\/j.jsha.2012.08.001_b0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus Warfarin in Patients with Atrial Fibrillation (ARISTOTLE)","volume":"365","author":"Granger","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsha.2012.08.001_b0155","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation (RE-LY)","volume":"361","author":"Connolly","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsha.2012.08.001_b0160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF)","volume":"365","author":"Patel","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsha.2012.08.001_b0165","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation (AVERROES)","volume":"364","author":"Connolly","year":"2011","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsha.2012.08.001_b0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)","volume":"163","author":"Kakkar","year":"2012","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1016\/j.jsha.2012.08.001_b0175","first-page":"477","article-title":"Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East","volume":"4","author":"Zubaid","year":"2011","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"4","key":"10.1016\/j.jsha.2012.08.001_b0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management","volume":"11","author":"Nabauer","year":"2009","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.jsha.2012.08.001_b0185","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2011.07.001","article-title":"Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF","volume":"162","author":"Piccini","year":"2011","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1016\/j.jsha.2012.08.001_b0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jclinepi.2010.04.022","article-title":"Uptake of methods to deal with publication bias in systematic reviews has increased over time, but there is still much scope for improvement","volume":"64","author":"Parekh-Bhurke","year":"2011","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Journal of the Saudi Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101673151200334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101673151200334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101673151200334X?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T17:41:50Z","timestamp":1666114910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S101673151200334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S101673151200334X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsha.2012.08.001","relation":{},"ISSN":["1016-7315"],"issn-type":[{"value":"1016-7315","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}